The consensus price target for Emergent BioSolutions has shifted from US$15 to US$12, with the modeled fair value sitting at US$12 per share. Analysts link this move to reduced earnings expectations ...

Joe Papa, President and Chief Executive Officer, who will provide an update on the company's 2025 business performance and multiyear transformation plan highlights; and Rich Lindahl, EVP and Chief ...

Detailed price information for Vertex Pharmaceutic (VRTX-Q) from The Globe and Mail including charting and trades.

HYDERABAD: The Greater Hyderabad Municipal Corporation (GHMC) and Malkajgiri Municipal Corporation (MMC) have asked property ...

The Iraqi government has approved plans for the East Baghdad (South) oilfield to proceed to a new development phase that will ...

I joined The Hatchet my first semester, knowing I wanted to write but not much else. GW was new to me, and covering Faculty Senate meetings and reading the Form 990s seemed daunting. But I’ve grown so ...

The average one-year price target for Emergent BioSolutions (NYSE:EBS) has been revised to $12.24 / share. This is a decrease of 11.11% from the prior estimate of $13.77 dated February 21, 2026. The ...

Amid feverish late-night negotiations 18 years ago, the then government, a coalition of Fianna Fáil and the Green Party, made ...

The April 2026 Oracle CPU includes 481 new security patches addressing 450 unique CVEs across 28 product families.

Global share markets sagged on Thursday as cracks quickly began to appear in the fragile Gulf truce, nudging oil prices back up toward $100 a barrel ...

Record revenue of $1.9 billion, up 14% Net income and diluted earnings per share both up 20% CHICAGO, April 22, 2026 /PRNewswire/ -- CME Group Inc. (NASDAQ: CME) ...

Recent share performance and business snapshot With no single headline event driving Erste Group Bank (WBAG:EBS) right now, the focus for investors tends to be on how the share price and underlying ...